학술논문
Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC
Document Type
Review
Author
Source
In: Expert Review of Anticancer Therapy . (Expert Review of Anticancer Therapy, 2024, 24(6):347-361)
Subject
Language
English
ISSN
17448328
14737140
14737140